Skip to main content
Erschienen in: Reactions Weekly 1/2018

01.06.2018 | Case report

Avibactam/ceftazidime

Treatment failure following the development of resistance in carbapenem-resistant Klebsiella pneumoniae infections: 8 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Shields RK, et al. Pneumonia and renal replacement therapy are risk factors for ceftazidime-avibactam treatment failures and resistance among patients with carbapenem-resistant enterobacteriaceae infections. Antimicrobial Agents and Chemotherapy 62: e02497-17, No. 5, May 2018. Available from: URL: http://doi.org/10.1128/AAC.02497-17 - USA Shields RK, et al. Pneumonia and renal replacement therapy are risk factors for ceftazidime-avibactam treatment failures and resistance among patients with carbapenem-resistant enterobacteriaceae infections. Antimicrobial Agents and Chemotherapy 62: e02497-17, No. 5, May 2018. Available from: URL: http://​doi.​org/​10.​1128/​AAC.​02497-17 - USA
Metadaten
Titel
Avibactam/ceftazidime
Treatment failure following the development of resistance in carbapenem-resistant Klebsiella pneumoniae infections: 8 case reports
Publikationsdatum
01.06.2018
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-018-47399-6

Weitere Artikel der Ausgabe 1/2018

Reactions Weekly 1/2018 Zur Ausgabe

Case report

Ocrelizumab

Case report

Dapsone

Case report

Lenvatinib